News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Smoking Has No Impact on Atazanavir Levels
July 23, 2010
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
VIENNA -- Cigarette smoking by patients infected with human immunodeficiency virus (HIV) does not appear to impact therapeutic levels of the protease inhibitor atazanavir (Reyataz), researchers said here at the 2010 International AIDS Conference.
Twitter
LinkedIn
Facebook
Email
Print